Performance verification and sigma metrics of creatinine assays
Journal Title: International Journal of Clinical Biochemistry and Research - Year 2018, Vol 5, Issue 1
Abstract
Introduction: Creatinine enzymatic method is more accurate but its own higher cost is the main reason why the use of Jaffe assays is still in practice. The verification step is performed because assay procedure confirms to the manufacturer’s claims in the end users’ setup. Desirable specification based on biological variation gives Allowable Total Error (ATE) and Sigma metrics provides summative evaluation of method performance. Objectives: Verification of manufacturer’s precision claims. Calculation of bias, Total Analytical Error (TAE) and sigma metrics. Materials and Methods: Modified Jaffe’s (No deproteinization) and enzymatic creatinine Erba XL liquid pack on Erba EM360 fully auto analyser were used. Intra assay and inter assay imprecision done on 20 replicates each. The estimates of bias uses data from precision experiment. Results & Discussion: The performance of jaffe’s and enzymatic serum creatinine is comparable to manufacturer's stated claimed value and are within desirable specification based on biological variation. The bias calculated in both assays is less than allowable bias. Total Analytical Error (TAE) is less than Allowable Total Error (ATE). Both the methods overall showed ATE ≥ bias + 4 SD. Within-run showed ATE ≥ bias + 5 SD complying Six Sigma concepts. Conclusion: Both Jaffe’s and enzymatic creatinine assays gives good performance and better sigma metrics. This makes enzymatic method a better choice due to inherent advantages such as increased accuracy and less interference if cost is neglected.
Authors and Affiliations
Santosh B. Jagtap, Sanjyoti S. Bandebuche, Mamata V. Hegde
Keywords
Related Articles
- EP ID EP472117
- DOI 10.18231/2394-6377.2018.0024
- Views 70
- Downloads 0
Evaluation of performance of Lipid Accumulation Product (LAP), an obesity index as a marker for diagnosing overt type 2 diabetes mellitus over Body Mass Index (BMI)
Objectives of the study: To compare the indices available to measure obesity such as BMI and “lipid accumulation product” (LAP) with respect to risk for development of Type-II Diabetes mellitus. Methodology: The study de...
Study of serum protein and electrophoretic pattern in pumonarytuberculosis patients
Tuberculosis one of the oldest diseases known to affect humans particularly in under developed and developing countries and is a major cause of death worldwide This study deals with the estimation of total serum proteins...
Is Placental Growth Factor an angiogenic marker in type 2 diabetes mellitus?
Introduction: Type 2 diabetes mellitus (T2DM) known by vascular complications due to abnormal angiogenesis leading to micro and macro vascular complications. PlGF a close homolog of VEGF, shares receptors with VEGF, and...
Prognostic significance of Ischemia Modified Albumin and role of high sensitive Creactive protein levels in acute ischemic stroke patients
Introduction: Acute ischemic stroke (AIS) is one of the leading cause of death worldwide and the main causes of long-term disability. Brain CT shows no abnormality in the early event of AIS and the infarct may not be see...
Relationship between sweat function determined by the sudoscan and parameters of the metabolic syndrome in people with type 2 diabetes
Objective The aim of this study was to investigate the relationship between the sweat function and parameters of the metabolic syndrome in type 2 diabetes patientsMaterials and Methods This was a crosssectional study whi...